Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays.

Li Y, Jortani SA, Ramey-Hartung B, Hudson E, Lemieux B, Kong H.

Clin Chim Acta. 2011 Jan 14;412(1-2):79-85. doi: 10.1016/j.cca.2010.09.014. Epub 2010 Sep 18.

PMID:
20854800
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2.

Aomori T, Yamamoto K, Oguchi-Katayama A, Kawai Y, Ishidao T, Mitani Y, Kogo Y, Lezhava A, Fujita Y, Obayashi K, Nakamura K, Kohnke H, Wadelius M, Ekström L, Skogastierna C, Rane A, Kurabayashi M, Murakami M, Cizdziel PE, Hayashizaki Y, Horiuchi R.

Clin Chem. 2009 Apr;55(4):804-12. doi: 10.1373/clinchem.2008.115295. Epub 2009 Jan 30.

PMID:
19181737
[PubMed - indexed for MEDLINE]
Free Article
3.

Distribution of CYP2C9 and VKORC1 risk alleles for warfarin sensitivity and resistance in the Israeli population.

Efrati E, Elkin H, Sprecher E, Krivoy N.

Curr Drug Saf. 2010 Jul 2;5(3):190-3.

PMID:
20210733
[PubMed - indexed for MEDLINE]
4.

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.

Yin T, Miyata T.

Thromb Res. 2007;120(1):1-10. Epub 2006 Dec 11. Review.

PMID:
17161452
[PubMed - indexed for MEDLINE]
5.

SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.

Huang SW, Li Q, Zhu SY, Li L, Xiong F, Jia YK, Xu XM.

Clin Chem Lab Med. 2009;47(1):26-31. doi: 10.1515/CCLM.2009.008.

PMID:
19117406
[PubMed - indexed for MEDLINE]
6.

Pharmacogenetic distribution of warfarin and its clinical significance in Korean patients during initial anticoagulation therapy.

Kwon A, Jo SH, Im HJ, Jo YA, Park JY, Kang HJ, Kim HS, Cho HC, Lee YK.

J Thromb Thrombolysis. 2011 Nov;32(4):467-73. doi: 10.1007/s11239-011-0616-3.

PMID:
21713378
[PubMed - indexed for MEDLINE]
7.

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

Scott SA, Edelmann L, Kornreich R, Desnick RJ.

Am J Hum Genet. 2008 Feb;82(2):495-500. doi: 10.1016/j.ajhg.2007.10.002. Epub 2008 Jan 17.

PMID:
18252229
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people.

Esmerian MO, Mitri Z, Habbal MZ, Geryess E, Zaatari G, Alam S, Skouri HN, Mahfouz RA, Taher A, Zgheib NK.

J Clin Pharmacol. 2011 Oct;51(10):1418-28. doi: 10.1177/0091270010382910. Epub 2010 Dec 8.

PMID:
21148049
[PubMed - indexed for MEDLINE]
9.

New genetic variant that might improve warfarin dose prediction in African Americans.

Schelleman H, Brensinger CM, Chen J, Finkelman BS, Rieder MJ, Kimmel SE.

Br J Clin Pharmacol. 2010 Sep;70(3):393-9. doi: 10.1111/j.1365-2125.2010.03709.x.

PMID:
20716240
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.

King CR, Porche-Sorbet RM, Gage BF, Ridker PM, Renaud Y, Phillips MS, Eby C.

Am J Clin Pathol. 2008 Jun;129(6):876-83. doi: 10.1309/1E34UAPR06PJ6HML.

PMID:
18480003
[PubMed - indexed for MEDLINE]
Free Article
11.

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.

Namazi S, Azarpira N, Hendijani F, Khorshid MB, Vessal G, Mehdipour AR.

Clin Ther. 2010 Jun;32(6):1050-60. doi: 10.1016/j.clinthera.2010.06.010.

PMID:
20637959
[PubMed - indexed for MEDLINE]
12.

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.

Miao L, Yang J, Huang C, Shen Z.

Eur J Clin Pharmacol. 2007 Dec;63(12):1135-41. Epub 2007 Sep 27.

PMID:
17899045
[PubMed - indexed for MEDLINE]
13.

Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic.

Shuen AY, Wong BY, Fu L, Selby R, Cole DE.

Clin Biochem. 2012 Apr;45(6):397-401. doi: 10.1016/j.clinbiochem.2012.01.002. Epub 2012 Jan 13.

PMID:
22266406
[PubMed - indexed for MEDLINE]
14.

Comparison of performance of three commercial platforms for warfarin sensitivity genotyping.

Babic N, Haverfield EV, Burrus JA, Lozada A, Das S, Yeo KT.

Clin Chim Acta. 2009 Aug;406(1-2):143-7. doi: 10.1016/j.cca.2009.06.015. Epub 2009 Jun 21.

PMID:
19545555
[PubMed - indexed for MEDLINE]
15.

Influence of CYP2C9 and vitamin k oxide reductase complex (VKORC)1 polymorphisms on time to determine the warfarin maintenance dose.

Aomori T, Obayashi K, Fujita Y, Araki T, Nakamura K, Nakamura T, Kurabayashi M, Yamamoto K.

Pharmazie. 2011 Mar;66(3):222-5.

PMID:
21553655
[PubMed - indexed for MEDLINE]
16.

New allele-specific real-time PCR system for warfarin dose genotyping equipped with an automatic interpretative function that allows rapid, accurate, and user-friendly reporting in clinical laboratories.

Kim S, Lee HW, Lee W, Um TH, Cho CR, Chun S, Min WK.

Thromb Res. 2012 Jul;130(1):104-9. doi: 10.1016/j.thromres.2011.08.021. Epub 2011 Sep 10.

PMID:
21911247
[PubMed - indexed for MEDLINE]
17.

Warfarin genotyping in a single PCR reaction for microchip electrophoresis.

Poe BL, Haverstick DM, Landers JP.

Clin Chem. 2012 Apr;58(4):725-31. doi: 10.1373/clinchem.2011.180356. Epub 2012 Feb 7.

PMID:
22317799
[PubMed - indexed for MEDLINE]
Free Article
18.

[Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].

Liu Y, Zhong SL, Yang M, Tan HH, Fei HW, Chen JY, Yu XY, Lin SG.

Beijing Da Xue Xue Bao. 2011 Dec 18;43(6):798-803. Chinese.

PMID:
22178823
[PubMed - indexed for MEDLINE]
Free Article
19.

ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese.

Zhu J, Zhang W, Li Y, Zhang W, Wang H, Zheng W, Wang C.

Pharmacogenomics. 2010 Jan;11(1):113-9. doi: 10.2217/pgs.09.138.

PMID:
20017677
[PubMed - indexed for MEDLINE]
20.

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.

Obayashi K, Nakamura K, Kawana J, Ogata H, Hanada K, Kurabayashi M, Hasegawa A, Yamamoto K, Horiuchi R.

Clin Pharmacol Ther. 2006 Aug;80(2):169-78.

PMID:
16890578
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk